Overview

Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers

Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of escalating single and multiple doses of the compound in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer